Position in IMCR
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$15,423,800
-$227,969 QoQ
Shares Held
485,789
-6.4% QoQ
Ownership
0.943%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#26
of 136 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRINCIPAL FINANCIAL GROUP INC holds $1,852,088,599 across 105 Biotechnology names. IMCR ranks #30 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
873,502 | $232,980,453 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
389,511 | $193,481,798 | |
| 3 | CYTK |
Cytokinetics Inc
|
1,311,664 | $111,740,655 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
1,752,753 | $94,070,253 | |
| 5 | INSM |
INSMED Inc
|
856,126 | $91,280,154 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
332,642 | $81,420,782 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,024,423 | $76,299,024 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
121,053 | $75,481,386 |
All Filings in IMCR
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,423,800 | 485,789 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $15,651,769 | 519,130 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $22,854,313 | 658,436 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $14,946,488 | 411,409 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $14,275,357 | 454,919 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $14,207,894 | 478,864 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $14,834,281 | 502,857 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $17,006,878 | 546,318 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $14,813,724 | 437,112 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $33,618,260 | 517,204 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $33,021,514 | 483,336 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $25,217,482 | 485,886 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $29,006,069 | 483,757 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $22,436,069 | 453,804 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $28,648,169 | 501,983 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $24,702,268 | 526,252 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $11,191,134 | 299,950 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $7,042,795 | 235,545 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $8,027,191 | 234,439 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $6,855,169 | 184,925 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $6,915,950 | 177,105 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $5,260,460 | 123,572 | Shares | Defined | 2021-05-24 | |
| No filing history on record for this holder in this stock. | ||||||